City National Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$92.5M Buy
3,903,834
+192,834
+5% +$4.65M 0.8% 36
2015
Q2
$88.1M Buy
3,711,000
+12,978
+0.4% +$293K 0.73% 38
2015
Q1
$87.8M Buy
3,698,022
+318,252
+9% +$7.14M 0.74% 39
2014
Q4
$71.8M Buy
3,379,770
+262,038
+8% +$5.26M 0.62% 51
2014
Q3
$53.1M Buy
3,117,732
+272,790
+10% +$4.31M 0.49% 70
2014
Q2
$40.7M Buy
2,844,942
+1,689,114
+146% +$22.9M 0.37% 94
2014
Q1
$14.3M Buy
+1,155,828
New +$13.3M 0.2% 137
2013
Q4
Sell
-39,870
Closed -$463K 852
2013
Q3
$463K Buy
+39,870
New +$466K 0.01% 524

Other funds holding EW

City National Bank's EW Position: Q3 2015 in Review

City National Bank increased its Edwards Lifesciences (EW) stake by 5.2% in Q3 2015, buying an estimated $4.65M and bringing the position to 3,903,834 shares worth $92.5M. The position accounts for 0.8% of the portfolio, ranked #36.

City National Bank first reported a position in EW in Q3 2013 and has held it in 8 quarters since. 568 funds tracked by Wall St. Rank hold EW as of Q3 2015.

  • City National Bank held 3,903,834 shares of Edwards Lifesciences worth $92.5M as of Q3 2015.
  • City National Bank bought 192,834 Edwards Lifesciences shares in Q3 2015, an estimated $4.65M.
  • Edwards Lifesciences made up 0.8% of City National Bank's portfolio in Q3 2015, its #36 holding.
  • City National Bank first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 8 quarters since.
  • 568 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.